A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma
β Scribed by Annie O. Chan; Man-Fung Yuen; Chee-Kin Hui; Wai-Kuen Tso; Ching-Lung Lai
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 68 KB
- Volume
- 94
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: Transcatheter arterial chemoembolization (tace) has been contra-indicated for the treatment of patients with hepatocellular carcinoma (hcc) and main portal vein (mpv) obstruction because of the potential risk of hepatic insufficiency resulting from ischemia after tace. the current co
## BACKGROUND. Transcatheter arterial chemoembolization (TACE) has been used as a palliative treatment for patients with unresectable hepatocellular carcinoma (HCC), but its prognostic usefulness has not previously been clarified. ## METHODS. The authors reviewed all patients treated at their ins